ALIPAY
16.9.2021 04:29:11 CEST | Business Wire | Press release
Fintech training platform 10x1000 Tech for Inclusion announced that it will deepen its collaborations with partners worldwide, working with leading global organizations, tech investors, and industry organizations to offer a program that enables aspiring practitioners to learn from global experts at their own pace.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210915006200/en/
Available from October through grants to over 1,000 learners, the Fintech Foundation Program Flex is a fully online certificate program providing practitioners with the mindset, knowledge and skills to become drivers of digital economic growth, according to 10x1000, a global and philanthropic fintech training initiative launched jointly by the International Finance Corporation (IFC), a member of the World Bank Group, and Alipay in 2018.
Flex learners will be recruited through partners such as the IFC (including the SME Finance Forum), United Nations Economic Commission for Africa, Dubai International Financial Centre, Malaysia Digital Economy Corporation, KPMG and fintech associations from Hong Kong, Malaysia, the Philippines, Thailand, and Singapore. (See table for a full list of 10X1000 partners)
“We are delighted to join hands with global partners to bring the 10x1000 training platform to learners worldwide, as we seek innovative approaches to meeting a common goal of bridging the digital skills gap, particularly in communities that need it the most,” said Eric Jing, Chairman and CEO of Ant Group, owner and operator of digital payments platform Alipay. “I am excited that learners from 10x1000’s new Flex program will gain the fintech knowledge they need to support their communities, and help bring us closer to meeting the UN Sustainable Development Goals (SDGs).”
“IFC has been a steadfast supporter of digital innovations that foster financial inclusion. As nations emerge from the Covid-19 pandemic, the world is in need of more visionary fintech leaders to drive such innovation and expand financial access,” said Qamar Saleem, Regional Manager for Advisory Services, Financial Institutions Group, Asia and Pacific, IFC. “We believe 10x1000’s Flex program will bring distinct value to complement existing educational resources with a flexible curriculum that draws on practical experience of leading fintech practitioners across regions.”
Through eight recorded video lectures, attendees of the new Flex program will hear directly from tech entrepreneurs, senior leaders at Ant and other fintech firms as well as distinguished scholars, sharing their first-hand knowledge on topics ranging from ‘the tech behind fintech’ and best practices in leveraging technology to solve real business problems.
Training content provided by 10x1000 is being guided by a Curriculum Steering Committee (CSC), an advisory body responsible for ensuring the quality and effectiveness of the curriculum. The current committee is composed of global experts from industry, academia, and international financial institutions.
Going forward, 10x1000 will also work with partners and alumni to cultivate a global fintech community, creating a vibrant platform that provides opportunities for willing organizations and individuals to contribute to global financial inclusion.
About 10x1000
10x1000 Tech for Inclusion is an open and global fintech training platform that enables learners to become drivers of digital economic growth. Its mission is to train 1,000 emerging talents and tech leaders each year for the next ten years. 10x1000 is a philanthropic initiative launched jointly by the International Finance Corporation (IFC), a member of the World Bank Group, and Alipay in 2018.
** 10x1000 Tech for Inclusion Partners List **
Founding Partners
1. Alipay (Alipay)
2. IFC (International Finance Corporation)
Global Organizations
1. UNECA (United Nations Economic Commission for Africa)
2. UNWFP (United Nations World Food Programme)
3. SME Finance Forum (SME Finance Forum, Managed by the IFC)
Regional-Country Industry Organizations
1. Africa’s Business Heroes (ABH)
2. DIFC (Dubai International Financial Centre)
3. FTAHK (FinTech Association of Hong Kong)
4. FAOM (FinTech Association of Malaysia)
5. Fintech Alliance PH Inc (Fintech Alliance.ph)
6. MDEC (Malaysia Digital Economy Corporation)
7. MFTA (MENA Fintech Association)
8. SFA (Singapore FinTech Association)
9. SLT (She Loves Tech)
10. TFA (Thai Fintech Association)
Professional Services/Investors
1. BAce Capital (BAce Capital)
2. Gobi Partners (Gobi Partners)
3. KPMG (KPMG)
4. 917Ventures (917Ventures)
** 10x1000 Curriculum Steering Committee Members (2021) **
Nafez Dakkak
Executive Chairman, Edraak.org
Pooma Kimis
Director, Bernstein Autonomous
Qamar Saleem
Regional Industry Manager Asia & Pacific, Financial Institutions Group at International Finance Corporation (IFC)
Daniel Suen
Head of Strategy, International Education, General Manager, China Education, Wiley
View source version on businesswire.com: https://www.businesswire.com/news/home/20210915006200/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press release
Potential first-in-class GPC3 x 4-1BB bispecific achieves a 36% confirmed response rate at Phase 3 dose and favorable safety profile in heavily pretreated liver cancerBrain-penetrant PRMT5 inhibitor shows promising antitumor and CNS activity in the largest publicly shared MTAP-deficient datasetFirst clinical data of CEA-targeting ADC demonstrates encouraging and sustained responses in CEAhigh NSCLC BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to dise
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release
- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release
New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release
Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom